학술논문

Combination of.. bispecific antibodies targeting innate (CEAxCD47, NILK-2401) and adaptive immunity (CEAxCD3, NILK-2301 and CEAxCD28, NILK-3301) for next generation immunotherapy of CEA-expressing cancers
Document Type
Journal
Source
CANCER RESEARCH; APR 1 2023, 83 7, 3p. Supplement: S
Subject
Language
English
ISSN
15387445